# Study to Investigate Adherence of Patients to Clodronate (Bonefos) Treatment

> **NCT01198457** · — · COMPLETED · sponsor: **Bayer** · enrollment: 147 (actual)

## Conditions studied

- Breast Neoplasms
- Prostatic Neoplasms
- Multiple Myeloma
- Osteolysis

## Interventions

- **DRUG:** Clodronate (Bonefos, BAY94-8393)

## Key facts

- **NCT ID:** NCT01198457
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2010-06
- **Final completion:** 2010-06
- **Target enrollment:** 147 (ACTUAL)
- **Last updated:** 2012-09-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01198457

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01198457, "Study to Investigate Adherence of Patients to Clodronate (Bonefos) Treatment". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT01198457. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*